The Daily Pulse

Science & Environment

University of Chicago scientists devise light‑driven carbon‑to‑nitrogen swap for drug molecules

Reported by Sneha Patil (Staff Writer) · The Hindu - Science ·

Unconfirmed — Reported by one source so far

Reported by one source so far

Worth knowing
University of Chicago scientists devise light‑driven carbon‑to‑nitrogen swap for drug moleculesRepresentative image · Wikimedia Commons

Chemists at the University of Chicago have created a mild, light‑driven reaction that swaps a carbon atom for a nitrogen atom in molecules commonly used in medical research and industry. The method uses a triplet‑state nitrene generated from aryl azides, blue light and oxygen to open a ring, rearrange atoms and close the ring with nitrogen in place of carbon. When applied to a stubborn indole substrate, the reaction gave a 73% yield of the nitrogen‑containing product. The team also modified a Vinca alkaloid cancer drug, producing a version with improved metabolic stability and reduced inhibition of the hERG potassium channel, a key safety marker. Nitrogen versions of the natural compounds yohimbine and catharanthine were also obtained, opening new routes for synthesising the chemotherapy precursor vinblastine. The authors note the technique is not universal and relies on toxic aryl azides, but claim the mild conditions and broad skeletal diversity give the method unexpected generality and potential value for medicinal chemistry. The findings were reported in Science on September 23, 2026.

ExplainerWhy this matters

What Happened

Scientists at the University of Chicago used blue light and oxygen to turn a reactive nitrene into a tool that replaces carbon atoms with nitrogen in drug‑like molecules.

Why It Matters

Swapping carbon for nitrogen can change how a drug dissolves, how it binds to targets, and its safety profile. The new method works under gentle conditions, avoiding harsh oxidants that can damage complex molecules, and it succeeded where older techniques failed, such as with indoles. Improved metabolic stability and lower hERG inhibition mean safer, more effective medicines can be designed faster.

What Happens Next

Researchers will test the reaction on a wider range of drug candidates and look for safer alternatives to the toxic aryl azides used as starting materials. If successful, the approach could become a standard step in medicinal chemistry labs, streamlining the creation of nitrogen‑rich drug scaffolds.

Read more at The Hindu - Science →